Q-Linea
0.042
SEK
-6.53 %
Less than 1K followers
QLINEA
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
-6.53%
-90.19%
-57.49%
-75.96%
-91.24%
-86.79%
-99.63%
-99.55%
-99.56%
Q-Linea operates in the medical technology sector. The company specializes in research and development of instruments and consumables. The products are mainly used in the treatment of infectious diseases and blood poisoning, and include diagnostic and analytical tools, as well as basic sample handling. The technology is based on the so-called ID and AST technology. Q-Linea was founded in 2008 and is headquartered in Uppsala.
Read moreMarket cap
184.6M SEK
Turnover
3.3M SEK
Revenue
2.36M
EBIT %
-9,052.54 %
P/E
-
Dividend yield-%
-
Financial calendar
3.4
2025
Extraordinary general meeting '25
29.4
2025
Interim report Q1'25
26.6
2025
General meeting '25
ShowingAll content types
Q-linea announces the initiation of another US ASTar evaluation
Redeye: Q-linea Q4 - Several commercial steps in the right direction
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools